PortfoliosLab logoPortfoliosLab logo
ISIN
US8636671013
CUSIP
863667101
IPO Date
Feb 1, 1988

Highlights

Market Cap
$117.76B
Enterprise Value
$143.33B
EPS (TTM)
$8.63
PE Ratio
35.29
PEG Ratio
2.62
Total Revenue (TTM)
$25.27B
Gross Profit (TTM)
$16.09B
EBITDA (TTM)
$5.48B
Year Range
$281.00 - $404.87
Target Price
$428.67
ROA (TTM)
7.21%
ROE (TTM)
7.21%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

SYK Performance Chart

Stryker Corporation (SYK) is down 13.1% since the beginning of the year. At $305 per share, SYK is trading 24.7% below its 52-week high of $405. Investors who bought $1,000 worth of SYK shares 5 years ago would now be looking at an investment worth $1,222.


Loading charts...

S&P 500 Index

Returns By Period

Stryker Corporation (SYK) has returned -13.08% so far this year and -18.09% over the past 12 months. Over the last ten years, SYK has returned 11.31% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Stryker Corporation

1D
-1.01%
1M
-3.73%
YTD
-13.08%
6M
-14.09%
1Y
-18.09%
3Y*
1.74%
5Y*
4.09%
10Y*
11.31%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

SYK Monthly Returns History

Based on dividend-adjusted daily data since Feb 1, 1988, SYK's average daily return is +0.08%, while the average monthly return is +1.67%. At this rate, an investment would double in approximately 3.5 years.

Historically, 58% of months were positive and 42% were negative. The best month was Dec 1991 with a return of +34.4%, while the worst month was Nov 2008 at -27.2%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.

On a daily basis, SYK closed higher 50% of trading days. The best single day was Apr 21, 1999 with a return of +27.2%, while the worst single day was Jan 28, 2000 at -17.5%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20265.15%4.84%-14.96%-4.10%-3.19%-0.13%-13.08%
20258.68%-1.30%-3.39%0.45%2.33%3.62%-0.73%-0.34%-5.34%-3.63%4.19%-5.07%-1.48%
202412.03%4.05%2.76%-5.97%1.36%-0.01%-3.76%10.07%0.46%-1.38%10.07%-7.97%21.34%
20233.81%3.57%8.89%4.97%-8.03%10.99%-7.11%0.05%-3.35%-1.12%9.66%1.33%23.80%
2022-7.24%6.17%1.78%-9.76%-2.80%-14.87%7.95%-4.45%-0.96%13.18%2.03%4.86%-7.42%
2021-9.81%9.81%0.63%7.82%-2.80%1.99%4.32%2.27%-4.60%0.89%-11.06%13.30%10.22%

Benchmark Metrics

Stryker Corporation has an annualized alpha of 13.17%, beta of 0.82, and R2 of 0.22 versus S&P 500 Index. Calculated based on daily prices since February 01, 1988.

  • This stock captured 118.64% of S&P 500 Index gains but only 80.93% of its losses - a favorable profile for investors.
  • R2 of 0.22 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
13.17%
Beta
0.82
0.22
Upside Capture
118.64%
Downside Capture
80.93%

Return for Risk

Risk / Return Rank

SYK ranks 12 for risk / return — in the bottom 12% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


SYK Risk / Return Rank: 1212
Overall Rank
SYK Sharpe Ratio Rank: 99
Sharpe Ratio Rank
SYK Sortino Ratio Rank: 1111
Sortino Ratio Rank
SYK Omega Ratio Rank: 1313
Omega Ratio Rank
SYK Calmar Ratio Rank: 1919
Calmar Ratio Rank
SYK Martin Ratio Rank: 88
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Stryker Corporation (SYK) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


SYKBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.82

Sortino ratioReturn per unit of downside risk

-3.78

Omega ratioGain probability vs. loss probability

0.88

1.37

-0.49

Calmar ratioReturn relative to maximum drawdown

-0.62

2.78

-3.40

Martin ratioReturn relative to average drawdown

-1.40

12.44

-13.84

Dividends

Dividend History

Stryker Corporation provided a 1.13% dividend yield over the last twelve months, with an annual payout of $3.44 per share. The company has been increasing its dividends for 16 consecutive years.


0.90%1.00%1.10%1.20%1.30%1.40%1.50%$0.00$0.50$1.00$1.50$2.00$2.50$3.00$3.5020152016201720182019202020212022202320242025
Dividends
Dividend Yield
PeriodTTM20252024202320222021202020192018201720162015
Dividend$3.44$3.40$3.24$3.05$2.84$2.59$2.36$2.14$1.93$1.75$1.57$1.42

Dividend yield

1.13%0.97%0.90%1.02%1.16%0.97%0.96%1.02%1.23%1.13%1.31%1.52%

Monthly Dividends

The table displays the monthly dividend distributions for Stryker Corporation. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026$0.00$0.00$0.88$0.00$0.00$0.00$0.88
2025$0.00$0.00$0.84$0.00$0.00$0.84$0.00$0.00$0.84$0.00$0.00$0.88$3.40
2024$0.00$0.00$0.80$0.00$0.00$0.80$0.00$0.00$0.80$0.00$0.00$0.84$3.24
2023$0.00$0.00$0.75$0.00$0.00$0.75$0.00$0.00$0.75$0.00$0.00$0.80$3.05
2022$0.00$0.00$0.70$0.00$0.00$0.70$0.00$0.00$0.70$0.00$0.00$0.75$2.84
2021$0.00$0.00$0.63$0.00$0.00$0.63$0.00$0.00$0.63$0.00$0.00$0.70$2.59

Dividend Yield & Payout


Dividend Yield

Stryker Corporation has a dividend yield of 1.13%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.

Payout Ratio

Stryker Corporation has a payout ratio of 38.48%, which is quite average when compared to the overall market. This suggests that Stryker Corporation strikes a balance between reinvesting profits for growth and paying dividends to shareholders.

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Stryker Corporation. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Stryker Corporation was 58.63%, occurring on Mar 9, 2009. Recovery took 1140 trading sessions.

The current Stryker Corporation drawdown is 23.93%.


Related event

Drawdown

Fall

Recovery

Underwater

Financial crisis2007–2009
-58.63%Mar 2009
1y 2mo4y 6mo
5y 8moDec 2007 - Sep 2013
1993 bear market1993
-57.00%Jun 1993
1y 5mo2y 5mo
3y 11moDec 1991 - Nov 1995
COVID crash2020
-43.80%Mar 2020
1mo 2d6mo 20d
7mo 22dFeb 2020 - Oct 2020
Dot-com crash2000–2002
-35.95%Mar 2000
1mo 18d3mo 8d
4mo 26dJan 2000 - Jun 2000
1998 bear market1998
-35.43%Oct 1998
5mo 26d2mo 15d
8mo 11dApr 1998 - Dec 1998

Drawdown Indicators


SYKBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-58.63%

-56.78%

-1.85%

Max Drawdown (1Y)

Largest decline over 1 year

-29.45%

-9.10%

-20.35%

Max Drawdown (3Y)

Largest decline over 3 years

-29.45%

-18.90%

-10.55%

Max Drawdown (5Y)

Largest decline over 5 years

-31.68%

-25.43%

-6.25%

Max Drawdown (10Y)

Largest decline over 10 years

-43.80%

-33.92%

-9.88%

Current Drawdown

Current decline from peak

-23.93%

-1.80%

-22.13%

Average Drawdown

Average peak-to-trough decline

-13.11%

-10.71%

-2.40%

Ulcer Index

Depth and duration of drawdowns from previous peaks

12.92%

2.03%

+10.89%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Stryker Corporation over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Stryker Corporation is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PE Ratio

The chart displays the Price-to-Earnings (P/E) ratio for SYK, comparing it with other companies in the Medical Devices industry. Currently, SYK has a P/E ratio of 35.3. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.

PEG Ratio

The chart shows the Price/Earnings to Growth (PEG) ratio for SYK compared to other companies in the Medical Devices industry. SYK currently has a PEG ratio of 2.6. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.

PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for SYK relative to other companies in the Medical Devices industry. Currently, SYK has a P/S ratio of 4.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for SYK in comparison with other companies in the Medical Devices industry. Currently, SYK has a P/B value of 2.5. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with SYK

Add Stryker Corporation to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with SYK